IP Library Granted Patent US 8,509,905
Granted Patent B2
US 8,509,905 · App. 13/447,026 · Granted Aug 13, 2013

Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,509,905
App. No.
13/447,026
Granted
Aug 13, 2013
Kind
B2
Abstract

Selective high-frequency spinal cord modulation for inhibiting pain with reduced side effects and associated systems and methods are disclosed. In particular embodiments, high-frequency modulation in the range of from about 1.5 KHz to about 50 KHz may be applied to the patient's spinal cord region to address low back pain without creating unwanted sensory and/or motor side effects. In other embodiments, modulation in accordance with similar parameters can be applied to other spinal or peripheral locations to address other indications.

Claims (51)

1. A method for treating a patient, comprising:

delivering or instructing delivery of an electrical therapy signal to the patient's spinal cord via at least one implantable signal delivery device to reduce or inhibit pain in the patient without the patient perceiving paresthesia, the signal having a frequency in a range of from about 1.5 kHz to about 50 kHz; and

continuing to deliver or instruct delivery of the electrical therapy signal without:

(a) changing or instructing the patient to change an amplitude of the signal in response to a change in patient position; or

(b) causing the system to change an amplitude of the signal in response to a change in patient position.

2. The method of claim 1 , wherein the method further comprises:

at a subsequent point in time, varying a current amplitude of the electrical therapy signal from a first amplitude value to a second, increased amplitude value that is more than 60% greater than the first value.

3. The method of claim 2 wherein reducing or inhibiting pain in the patient without the patient perceiving paresthesia is maintained as the current amplitude is varied from the first amplitude value to the second amplitude value.

4. The method of claim 1 , further comprising:

placing or instructing placement of the at least one signal delivery device at a position lateral of a midline of the spinal cord as at least part of a placement process, without using patient feedback during the placement process to at least assist in selecting the position.

5. The method of claim 4 wherein the position has an axial location and a lateral location, and wherein placing or instructing placement includes identifying or instructing identification of the position of the at least one signal delivery device without using or instructing use of patient feedback to adjust one of (a) the axial location of the at least one signal delivery device, or (b) the lateral location of the at least one signal delivery device.

6. The method of claim 4 wherein the position has an axial location and a lateral location, and wherein placing or instructing placement includes identifying or instructing identification of the position of the at least one signal delivery device without using or instructing use of patient feedback to adjust both (a) the axial location of the at least one signal delivery device, and (b) the lateral location of the at least one signal delivery device.

7. The method of claim 1 wherein the electrical therapy signal reduces or inhibits at least one of low-back pain and leg pain.

8. The method of claim 1 the electrical therapy signal reduces or inhibits both low-back pain and leg pain.

9. The method of claim 1 wherein the electrical therapy signal has a frequency of from about 5 kHz to about 15 kHz.

10. The method of claim 1 wherein the electrical therapy signal has a frequency of from about 3 kHz to about 15 kHz.

11. The method of claim 1 wherein the electrical therapy signal has a frequency of from about 3 kHz to about 20 kHz.

12. The method of claim 1 wherein the electrical therapy signal has a frequency of from about 3 kHz to about 10 kHz.

13. The method of claim 1 wherein the electrical therapy signal has a frequency of about 10 kHz.

14. A method for treating a patient, comprising:

delivering an electrical therapy signal to the patient's spinal cord via at least one implanted signal delivery device to reduce or inhibit pain in the patient without the patient perceiving paresthesia, the signal having a frequency in a range of from about 1.5 kHz to about 50 kHz; and

continuing deliver the electrical therapy signal without:

(a) changing or instructing the patient to change an amplitude of the signal in response to a change in patient activity; or

(b) causing the system to change an amplitude of the signal in response to a change in patient activity.

15. The method of claim 14 , wherein the method further comprises:

at a subsequent point in time, varying a current amplitude of the electrical therapy signal from a first amplitude value to a second, increased amplitude value that is more than 60% greater than the first value.

16. The method of claim 15 wherein reducing or inhibiting pain in the patient without the patient perceiving paresthesia is maintained as the current amplitude is varied from the first amplitude value to the second amplitude value.

17. The method of claim 14 , further comprising:

placing or instructing placement of the at least one signal delivery device at a position lateral of a midline of the spinal cord as at least part of a placement process, without using patient feedback during the placement process to at least assist in selecting the position.

18. The method of claim 17 wherein the position has an axial location and a lateral location, and wherein placing or instructing placement includes identifying or instructing identification of the position of the at least one signal delivery device without using or instructing use of patient feedback to adjust one of (a) the axial location of the at least one signal delivery device, or (b) the lateral location of the at least one signal delivery device.

19. The method of claim 14 wherein the electrical therapy signal reduces or inhibits at least one of low-back pain and leg pain.

20. The method of claim 14 wherein the electrical therapy signal has a frequency of from about 5 kHz to about 15 kHz.

21. The method of claim 14 wherein the electrical therapy signal has a frequency of from about 3 kHz to about 15 kHz.

22. The method of claim 14 wherein the electrical therapy signal has a frequency of from about 3 kHz to about 20 kHz.

23. The method of claim 14 wherein the electrical therapy signal has a frequency of from about 3 kHz to about 10 kHz.

24. The method of claim 14 wherein the electrical therapy signal has a frequency of about 10 kHz.

25. A method for treating a patient, comprising:

delivering or instructing delivery of an electrical therapy signal to the patient's spinal cord via at least one implanted signal delivery device to reduce or inhibit pain to the patient without the patient perceiving paresthesia, the signal having a frequency in a range of from about 1.5 kHz to about 50 kHz; and

continuing to deliver or instruct delivery of the electrical therapy signal without:

(a) changing or instructing the patient to change an amplitude of the signal in response to a change in patient sleep state; or

(b) causing the system to change an amplitude of the signal in response to a change in patient sleep state.

26. The method of claim 25 , wherein the method further comprises:

at a subsequent point in time, varying a current amplitude of the electrical signal from a first amplitude value to a second, increased amplitude value that is more than 60% greater than the first value.

27. The method of claim 26 wherein reducing or inhibiting pain in the patient without the patient perceiving paresthesia is maintained as the current amplitude is varied from the first amplitude value to the second amplitude value.

28. The method of claim 25 , further comprising:

placing or instructing placement of the at least one signal delivery device at a position lateral of a midline of the spinal cord as at least part of a placement process, without using patient feedback during the placement process to at least assist in selecting the position.

29. The method of claim 25 wherein the electrical therapy signal reduces or inhibits at least one of low-back pain and leg pain.

30. The method of claim 25 wherein the electrical therapy signal has a frequency of from about 5 kHz to about 15 kHz.

31. The method of claim 25 wherein the electrical therapy signal has a frequency of from about 3 kHz to about 15 kHz.

32. The method of claim 25 wherein the electrical therapy signal has a frequency of from about 3 kHz to about 20 kHz.

33. The method of claim 25 wherein the electrical therapy signal has a frequency of from about 3 kHz to about 10 kHz.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Apr 4, 2025
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
To: NEVRO CORP.
Reel/Frame 070743/0001 →
PATENT SECURITY AGREEMENT Recorded Dec 1, 2023
From: NEVRO CORP.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 065744/0302 →
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY DATA NAME PREVIOUSLY RECORDED AT REEL: 030694 FRAME: 0063. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT . Recorded Nov 21, 2016
From: ALATARIS, KONSTANTINOS; WALKER, ANDRE B.; PARKER, JON; CHITRE, YOUGANDH; PARK, SANGSOO WESLEY; THACKER, JAMES R.
To: NEVRO CORP.
Reel/Frame 040656/0260 →
RELEASE OF SECURITY INTEREST Recorded Jun 27, 2016
From: CRG SERVICING LLC
To: NEVRO CORP.
Reel/Frame 039168/0890 →
ASSIGNMENT AGREEMENT (REAFFIRMATION) Recorded Jun 13, 2016
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: CRG SERVICING LLC,
Reel/Frame 038984/0865 →
SECURITY INTEREST Recorded Dec 12, 2014
From: NEVRO CORP.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 034619/0546 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 26, 2013
From: ALATARIS, KONSTANTINOS; WALKER, ANDRE B.; PARKER, JON; CHITRE, YOUGANDH; PARK, SANGSOO WESLEY; THACKER, JAMES R.
To: NEVRO CORPORATION
Reel/Frame 030694/0063 →